CYP2D6 and Alzheimer disease: Those associated with normal ageing and not AD, which may therefore be protective against AD, are involved in monoamine metabolism, methylation, and signalling (MAOA, ADRB1, COMT), and detox pathways (CYP2D6, SOD2, GSTM1).